Gopichand who was until last year written off as future prospect,
suddenly staged a spectacular comeback with the super success of
Loukyam. The movie went on to rake in about 18 Crore share Worldwide
bringing Gopichand back to success streak. Buoyed by the success of
Loukyam, his next film, Jil is getting superb offers in trade.
Jil reportedly fetched 19.5 Crore for the theatrical rights for the makers which is so far the best in Gopichand's career. The Satellite rights, dubbing, remake and others likely to fetch about 5 Crore which means the makers will easily get a table profit of 8 Crore minimum given that rest of the cast and crew of the film are relatively new.
Jil is marked for March 27th release. There are positive vibes about the film so far. UV Creations, the production house of the film so far had churned two successes - Mirchi and Run Raja Run. Recently released Music of the film scored by Ghibran has got good reviews and so every thing looks positive about the film.
Here are the Pre-release business details of Gopichand's Jil:
Andhra : 8 Crore
Ceeded : 3 Crore
Nizam : 6 Crore advance
KA+ROI+OS : 2.5 Crore
Total : 19.5Cr
Highest ever in Gopichand's career.
Jil reportedly fetched 19.5 Crore for the theatrical rights for the makers which is so far the best in Gopichand's career. The Satellite rights, dubbing, remake and others likely to fetch about 5 Crore which means the makers will easily get a table profit of 8 Crore minimum given that rest of the cast and crew of the film are relatively new.
Jil is marked for March 27th release. There are positive vibes about the film so far. UV Creations, the production house of the film so far had churned two successes - Mirchi and Run Raja Run. Recently released Music of the film scored by Ghibran has got good reviews and so every thing looks positive about the film.
Here are the Pre-release business details of Gopichand's Jil:
Andhra : 8 Crore
Ceeded : 3 Crore
Nizam : 6 Crore advance
KA+ROI+OS : 2.5 Crore
Total : 19.5Cr
Highest ever in Gopichand's career.
No comments:
Post a Comment